Xin Liu
Vorstandsvorsitzender bei National Innovation Center for High Performance Medical
Profil
Xin Liu is an Independent Non-Executive Director at Insight Lifetech Co., Ltd., a Professor at The Shenzhen Institutes of Advanced Technology, and the General Manager at National Innovation Center for High Performance Medical.
Liu received a graduate degree from Wuhan University in 1993 and an undergraduate degree from the same university in 1988.
Aktive Positionen von Xin Liu
Unternehmen | Position | Beginn |
---|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | 30.06.2021 |
The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 01.02.2010 |
National Innovation Center for High Performance Medical | Vorstandsvorsitzender | 01.02.2021 |
Ausbildung von Xin Liu
Wuhan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
National Innovation Center for High Performance Medical |